FDA To Appeal Ruling On 180-Day Shared Exclusivity
U.S. regulators are preparing an appeal of a recent court decision that barred the Food and Drug Administration from granting shared 180-day exclusivity to several makers of generic versions of branded...To view the full article, register now.
Already a subscriber? Click here to view full article